A recent study demonstrated the efficacy of a humanized anti-OPN antibody in inhibiting breast cancer growth and metastasis in vivo [42], the efficacy of targeting OPN in CRC treatment by this anti-OPN antibody or other inhibitors warrants further investigations. The gene discussed is SPP1; the disease is colorectal carcinoma.